AtkinsRéalis appoints Michael Reynolds as Managing Director, Nuclear EMEA

As part of his role, Michael will oversee more than 2,000 nuclear professionals across EMEA, leading the continued growth and delivery of AtkinsRéalis’ Nuclear business in the region and supporting clients in delivering their strategic priorities.

Michael has extensive experience across AtkinsRéalis and has held several senior leadership positions within the business. His previous roles include Practice Director in Transportation, Business Manager for Nuclear Operations and, most recently, Nuclear EMEA Operations and Commercial Director.

Joe St. Julian, President, AtkinsRéalis Nuclear, said: “Michael brings a deep understanding of our business, strong operational leadership and a clear commitment to our people and clients. Having successfully led Nuclear EMEA on an interim basis since March, he is exceptionally well positioned to take the business forward as we continue to grow our capabilities and support our clients across the region.

“I’m delighted to welcome Michael to the role permanently and look forward to working with him as we deliver the next chapter of growth for our Nuclear business in EMEA.

”Michael Reynolds, Managing Director, Nuclear EMEA, AtkinsRéalis, said: “Nuclear is entering a significant period of growth across EMEA, with an increasingly important role to play in countries’ long-term energy strategies. The challenge now is turning that ambition into successful programmes, bringing together the right expertise, experience and delivery capability.

“My priority is to build on our strong foundations; bringing together the breadth of expertise across AtkinsRéalis to ensure we continue to deliver for our clients as the nuclear market evolves.”

About AtkinsRéalis’ Nuclear Business

AtkinsRéalis has over 70 years of global nuclear expertise, delivering nuclear technology products and full-service solutions to nuclear utilities around the world. AtkinsRéalis is the steward of CANDU® nuclear technology, operating on four continents, and provides advisory and engineering services to other nuclear developers. With an innovative technology portfolio, including access to over 500 patented solutions, AtkinsRéalis solves technically complex challenges across the whole nuclear lifecycle from design and new build through asset management and from life extension and late life management through decommissioning and waste management. AtkinsRéalis operates and manages government nuclear research sites, transforming ageing infrastructure and safely managing legacy nuclear waste. AtkinsRéalis’ CANDU technology also allows for the co-production of medical radioisotopes for cancer detection and treatment. The company also supports cancer treatment through its partnership with TerraPower to extract isotopes from legacy nuclear material. Learn more on our Nuclear market page.